Emergent BioSolutions Inc.NYSE: EBS

Emergent BioSolutions to Participate in Jefferies Global Healthcare Conference

· Issued by Emergent BioSolutions Inc. via Business Wire

Summary by 6ix AI

Emergent BioSolutions Inc., which makes products for health threats such as smallpox, anthrax and opioid overdose emergencies, said members of its senior management team will take part in the Jefferies Global Healthcare Conference in London, November 16-19, 2026.

Key details

  • Management will present via webcast on November 18 at 8:00am – 8:25am UTC/GMT (3:00am ET).
  • A replay of the presentation will be available for approximately three months.
  • One-on-one meetings can be requested through a conference representative.

6ix AI wrote this summary from the release below and checked it against the release.

GAITHERSBURG, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Jefferies Global Healthcare Conference in London, November 16-19, 2026.

Management will present via webcast on November 18 at 8:00am – 8:25am UTC/GMT (3:00am ET). A replay of the presentation will be available on the webcast page linked above for approximately three months. Visit Emergent’s Investor Relations page to learn more. Please contact a conference representative to request a one-on-one meeting.

About Emergent BioSolutions

At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

View original source (Business Wire)Emergent BioSolutions Inc. on 6ix

Story so far

Earlier from Emergent BioSolutions

Later from Emergent BioSolutions

All Emergent BioSolutions news releases